These results showed that combination treatment of eribulin plus the AKT inhibitor MK-2206 inhibited the proliferation of STS cells and this was accompanied by G1 or G2/M arrest with the down-regulation of CDK4/6, cdc2 and cyclin B1/D3. This evidence concerns the gene AKT1 and telomere syndrome.